ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 5, 1974

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage.

October 19, 2007

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

New Organization To Develop Curriculum To Teach Oncologists How To Talk To Patients.

January 19, 2001

Supreme Court Lets Stand Lower Court Ruling On AZT Patents

January 19, 1996